Analyze Diet

The rapid and effective administration of a beta 2-agonist to horses with heaves using a compact inhalation device and metered-dose inhalers.

Abstract: The purpose of the study was to administer therapeutic aerosol generated by metered-dose inhalers to horses exhibiting clinical signs of heaves using a compact inhalation device developed for human medicine. It was fitted to a custom face mask in order to study the effect of an inhaled beta 2-agonist, fenoterol. Pulmonary function testing was performed on six horses following an acute exacerbation of heaves, characterized by tachypnea, wheezes, crackles, and spasmodic cough. Horses inhaled fenoterol in 1 mg increments administered as one 200 microgram puff every 5-10 s with the recording of data 5 min after the cessation of drug inhalation. A significant effect of fenoterol was shown for maximum change in transpulmonary pressure, dynamic compliance, lung resistance, and work of breathing, and the wheezes and crackles disappeared when auscultation was performed at the end of the test. This study demonstrates a novel, highly effective method for the rapid administration of inhaled medication in horses.
Publication Date: 1994-03-01 PubMed ID: 8055432PubMed Central: PMC1686335
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research tested a new method to quickly deliver aerosol medication to horses suffering from heaves, using a compact inhalation device designed for humans. The medication, a beta 2-agonist called fenoterol, had a significant effect, improving lung function and reducing symptoms in the horses.

Research Objective

  • The research aimed to test the effectiveness of administering aerosol medication to horses showing symptoms of heaves, a respiratory disease, using a compact inhalation device typically utilized in human medicine. The medication used in this study was an inhaled beta 2-agonist, fenoterol.

Research Methodology

  • Six horses that had experienced an acute exacerbation of heaves (with symptoms such as tachypnea, wheezes, crackles, and spasmodic cough) were selected for the study.
  • The inhalation device was fitted to a custom face mask for each horse. The medication was then administered in 1 mg increments with each puff of the inhaler containing 200 micrograms of fenoterol.
  • Each administration was followed by a 5-10 seconds rest period, and data was recorded 5 minutes after the cessation of drug inhalation.

Results and Conclusion

  • The study showed a significant impact of fenoterol on several parameters – maximum change in transpulmonary pressure, dynamic compliance, lung resistance, and work of breathing. In addition, there was a disappearance of wheezes and crackles when auscultation was performed at the end of the test.
  • In conclusion, the study showed promising results for a new, more effective method for quickly delivering aerosol drugs to horses with heaves using a compact inhalation device. This device, usually used in human medicine, was adapted for use with horses and showed potential for improving treatment of respiratory diseases in equine veterinary practice.

Cite This Article

APA
Tesarowski DB, Viel L, McDonell WN, Newhouse MT. (1994). The rapid and effective administration of a beta 2-agonist to horses with heaves using a compact inhalation device and metered-dose inhalers. Can Vet J, 35(3), 170-173.

Publication

ISSN: 0008-5286
NlmUniqueID: 0004653
Country: Canada
Language: English
Volume: 35
Issue: 3
Pages: 170-173

Researcher Affiliations

Tesarowski, D B
  • Firestone Equine Respiratory Research Laboratory, Department of Clinical Studies, Ontario Veterinary College, University of Guelph.
Viel, L
    McDonell, W N
      Newhouse, M T

        MeSH Terms

        • Administration, Inhalation
        • Aerosols
        • Airway Obstruction / drug therapy
        • Airway Obstruction / veterinary
        • Analysis of Variance
        • Animals
        • Fenoterol / administration & dosage
        • Horse Diseases / drug therapy
        • Horses
        • Nebulizers and Vaporizers / veterinary
        • Respiratory Function Tests / veterinary

        References

        This article includes 19 references
        1. Asmundsson T, Johnson RF, Kilburn KH, Goodrich JK. Efficiency of nebulizers for depositing saline in human lung.. Am Rev Respir Dis 1973 Sep;108(3):506-12.
          pubmed: 4583166doi: 10.1164/arrd.1973.108.3.506google scholar: lookup
        2. Newhouse M. Advantages of pressurized canister metered dose inhalers.. J Aerosol Med 1991 Fall;4(3):139-50.
          pubmed: 10147675doi: 10.1089/jam.1991.4.139google scholar: lookup
        3. Idris AH, McDermott MF, Raucci JC, Morrabel A, McGorray S, Hendeles L. Emergency department treatment of severe asthma. Metered-dose inhaler plus holding chamber is equivalent in effectiveness to nebulizer.. Chest 1993 Mar;103(3):665-72.
          pubmed: 8449049doi: 10.1378/chest.103.3.665google scholar: lookup
        4. Heel RC, Brogden RN, Speight TM, Avery GS. Fenoterol: a review of its pharmacological properties and therapeutic efficacy in asthma.. Drugs 1978 Jan;15(1):3-32.
        5. Halliwell RE, Fleischman JB, Mackay-Smith M, Beech J, Gunson DE. The role of allergy in chronic pulmonary disease of horses.. J Am Vet Med Assoc 1979 Feb 1;174(3):277-81.
          pubmed: 571867
        6. McPherson EA, Lawson GH, Murphy JR, Nicholson JM, Breeze RG, Pirie HM. Chronic obstructive pulmonary disease (COPD) in horses: aetiological studies: responses to intradermal and inhalation antigenic challenge.. Equine Vet J 1979 Jul;11(3):159-66.
        7. Breeze RG. Heaves. The problem of disease definition.. Vet Clin North Am Large Anim Pract 1979 May;1(1):219-30.
          pubmed: 315644doi: 10.1016/s0196-9846(17)30207-0google scholar: lookup
        8. Yu CP, Nicolaides P, Soong TT. Effect of random airway sizes on aerosol deposition.. Am Ind Hyg Assoc J 1979 Nov;40(11):999-1005.
          pubmed: 532787doi: 10.1080/15298667991430613google scholar: lookup
        9. Murphy JR, McPherson EA, Dixon PM. Chronic obstructive pulmonary disease (COPD): effects of bronchodilator drugs on normal and affected horses.. Equine Vet J 1980 Jan;12(1):10-4.
        10. Dolovich M, Ruffin RE, Roberts R, Newhouse MT. Optimal delivery of aerosols from metered dose inhalers.. Chest 1981 Dec;80(6 Suppl):911-5.
          pubmed: 7307637
        11. Dolovich M, Ruffin R, Corr D, Newhouse MT. Clinical evaluation of a simple demand inhalation MDI aerosol delivery device.. Chest 1983 Jul;84(1):36-41.
          pubmed: 6861546doi: 10.1378/chest.84.1.36google scholar: lookup
        12. Thomson JR, McPherson EA. Chronic obstructive pulmonary disease in the horse. 2: Therapy.. Equine Vet J 1983 Jul;15(3):207-10.
        13. Shim CS, Williams MH Jr. Effect of bronchodilator therapy administered by canister versus jet nebulizer.. J Allergy Clin Immunol 1984 Mar;73(3):387-90.
          pubmed: 6699319doi: 10.1016/0091-6749(84)90413-5google scholar: lookup
        14. Clay MM, Clarke SW. Wastage of drug from nebulisers: a review.. J R Soc Med 1987 Jan;80(1):38-9.
          pubmed: 3550079doi: 10.1177/014107688708000115google scholar: lookup
        15. Broadstone RV, Scott JS, Derksen FJ, Robinson NE. Effects of atropine in ponies with recurrent airway obstruction.. J Appl Physiol (1985) 1988 Dec;65(6):2720-5.
          pubmed: 3215872doi: 10.1152/jappl.1988.65.6.2720google scholar: lookup
        16. Conner WT, Dolovich MB, Frame RA, Newhouse MT. Reliable salbutamol administration in 6- to 36-month-old children by means of a metered dose inhaler and Aerochamber with mask.. Pediatr Pulmonol 1989;6(4):263-7.
          pubmed: 2748223doi: 10.1002/ppul.1950060410google scholar: lookup
        17. Fuller HD, Dolovich MB, Posmituck G, Pack WW, Newhouse MT. Pressurized aerosol versus jet aerosol delivery to mechanically ventilated patients. Comparison of dose to the lungs.. Am Rev Respir Dis 1990 Feb;141(2):440-4.
          pubmed: 2154154doi: 10.1164/ajrccm/141.2.440google scholar: lookup
        18. Wong CS, Pavord ID, Williams J, Britton JR, Tattersfield AE. Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma.. Lancet 1990 Dec 8;336(8728):1396-9.
          pubmed: 1978872doi: 10.1016/0140-6736(90)93099-bgoogle scholar: lookup
        19. Bremner P, Burgess CD, Crane J, McHaffie D, Galletly D, Pearce N, Woodman K, Beasley R. Cardiovascular effects of fenoterol under conditions of hypoxaemia.. Thorax 1992 Oct;47(10):814-7.
          pubmed: 1481183doi: 10.1136/thx.47.10.814google scholar: lookup

        Citations

        This article has been cited 1 times.
        1. Mazan MR, Lascola K, Bruns SJ, Hoffman AM. Use of a novel one-nostril mask-spacer device to evaluate airway hyperresponsiveness (AHR) in horses after chronic administration of albuterol. Can J Vet Res 2014 Jul;78(3):214-20.
          pubmed: 24982553